Keywords: hold, up, abbott, fda, says, zileuton, dossier

Hold Up For Abbott As FDA Says No To Zileuton Dossier

Article | 30 October 1995

Abbott Laboratories, which is seeking to become the first company to bring a 5-lipoxygenase inhibitor to the US market, has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in